Animace načítání

Stránka se připravuje...


Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

XXXXXXXX KOMISE X XXXXXXXXX PRAVOMOCI (EU) 2020/217

xx xxx 4. xxxxx 2019,

kterým xx xxx účely přizpůsobení xxxxxxxxxxxxxxxxxx xxxxxxx mění xxxxxxxx Xxxxxxxxxx parlamentu x Xxxx (XX) x. 1272/2008 x xxxxxxxxxxx, označování x xxxxxx látek a xxxxx a xxxxxx xx xxxxxxx nařízení xxxxxxxx

(Xxxx s xxxxxxxx xxx XXX)

XXXXXXXX XXXXXX,

x xxxxxxx xx Xxxxxxx x xxxxxxxxx Xxxxxxxx xxxx,

x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (ES) x. 1272/2008 xx xxx 16. prosince 2008 x xxxxxxxxxxx, xxxxxxxxxx x xxxxxx xxxxx x směsí, x xxxxx a xxxxxxx xxxxxxx 67/548/XXX x 1999/45/XX a x změně xxxxxxxx (XX) x. 1907/2006 (1), x zejména xx xx. 37 odst. 5 x xx. 53 xxxx. 1 xxxxxxxxx xxxxxxxx,

xxxxxxxx k xxxxx xxxxxxx:

(1)

Xxxxxxx 3 x xxxxx 3 xxxxxxx XX xxxxxxxx (XX) x. 1272/2008 xxxxxxxx xxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx x označení xxxxxxxxxxxx látek na xxxxxxx xxxxxxxx xxxxxxxxxxx x xxxxxxx 2 xx 5 xxxxxxx X uvedeného xxxxxxxx.

(2)

Evropské xxxxxxxx xxx chemické xxxxx (xxxx xxx „xxxxxxxx“) xxxx x xxxxxxx x xxxxxxx 37 xxxxxxxx (ES) x. 1272/2008 xxxxxxxxxx xxxxxx xx xxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxx x xxxxxxxx některých látek x aktualizaci xxxx xxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx x xxxxxxxx některých xxxxxx látek. Xx xxxxxxx stanovisek x xxxxx návrhům, xxxxx xxxxx Xxxxx xxx xxxxxxxxxx xxxxx (XXX) xxxxxxxx, xxxxx x xxxxxxxxxx xxxxxxxxxxxx xxxxx, xx xxxxxx xxxxxx, xxxxxxxxxxxx xx zrušit xxxxxxxxxxxxx xxxxxxxxxxx x xxxxxxxx xxxxxxxxx xxxxx. Xxxxxxx xxxxxxxxxx výboru XXX (2) xxxx:

xxxxxxxxxx xx xxx 9. xxxxxx 2017 xxx xxxxxxx x 4,4’-xxxxxxxxxxxxxxxx, fenolu, xxxxxxxx xxxxxxxxxxxx a xxxxxxxx amonného (XX4Xx),

xxxxxxxxxx xx xxx 22. xxxx 2017 xxx xxxxxxxxx-4-xxxxx-6-{[4-({4-[(2,4-xxxxxxxxxxxx)xxx]xxxxx}xxxxxxxxx)xxxxx]xxx}-5-xxxxxxx-3-[(4-xxxxxxxxxx)xxx]-xxxxxxxx-2,7-xxxxxxxxxx,

xxxxxxxxxx xx dne 9. června 2017 xxx xxxxxxxx(2,4,6-xxxxxxxxxxxxxxxx)xxxxxxxxxx,

stanovisko xx xxx 22. xxxx 2017 xxx kobalt,

stanovisko xx dne 22. xxxx 2017 xxx xxxx-xxx(xxxxxxxxxx); nikl-sulfamát,

stanovisko xx xxx 22. xxxx 2017 xxx xxxxxxxxxxx; xxxxxx,

xxxxxxxxxx xx xxx 22. xxxx 2017 xxx 2,4,6,8-xxxxxxxxxxx-1,3,5,7-xxxxxxxxxxxxxxxxxx; xxxxxxxxxx,

xxxxxxxxxx xx xxx 15. xxxxxx 2017 xxx 2-xxxxxx-2-xxxxxxxxxxxxx-1-(4-xxxxxxxxxxxxxx)xxxxx-1-xx,

xxxxxxxxxx ze xxx 5. prosince 2017 xxx xxxxxxx (ISO); X-(6-xxxxx-3-xxxxxxxxxxxxxx-4-xx)-X-xxxxx-xxxxxxxxxxxx,

xxxxxxxxxx ze xxx 22. září 2017 xxx dodecyl-methakrylát,

xxxxxxxxxx ze xxx 5. prosince 2017 pro 2-xxxxxxxxxxxxxxxx,

xxxxxxxxxx xx xxx 15. xxxxxx 2017 pro xxxxxxxxxxxx (ISO); 2-(xxxxxxx-4-xx)xxxxxxxxxxxx,

stanovisko xx xxx 9. xxxxxx 2017 pro X,X-xxxxxxx-x-xxxxxxxx; deet;

stanovisko xx xxx 14. září 2017 xxx xxxx xxxxxxxxxx,

xxxxxxxxxx xx dne 15. xxxxxx 2017 xxx xxxxxxx xxxxxxxxxxx,

xxxxxxxxxx xx dne 9. xxxxxx 2017 xxx xxxxx[xxx]xxxxxxxx,

xxxxxxxxxx ze xxx 9. června 2017 xxx xxxxxxx[x,xxx]xxxxxxx;xxxxxxx[x,x]xxxxx,

stanovisko ze xxx 22. xxxx 2017 xxx xxxxxxx, 2,2’-xxxxxxxx-, X-(X13-15-xxxxxxxxxx a xxxxxxxx alkyl) xxxxxxxx,

xxxxxxxxxx xx dne 5. xxxxxxxx 2017 xxx xxxxxxxxxxxx (XXX); 2-xxxxxxxxxxxx-(XX)-2-(4-xxxx-xxxxxxxxxx)-2-xxxxx-3-xxx-3-(α,α,α-xxxxxxxx-x-xxxxx)xxxxxxxxx,

stanovisko xx dne 9. xxxxxx 2017 pro xxxxxxxxxxx-2,2‘,2“,2“‘,2“"-(xxxxx-1,2-xxxxxxxxxx)xxxxxxxxxxx,

xxxxxxxxxx xx xxx 9. června 2017 xxx {[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxxx xxxxxxxx,

xxxxxxxxxx xx xxx 9. xxxxxx 2017 xxx xxxxxxxxxxxx-[(xxxxxxxxxxxxxxxxx)xxxxxxxx(xxxxxxxxxxxxx)xxxxxxxxxxx],

xxxxxxxxxx xx xxx 9. xxxxxx 2017 xxx xxxxxxxxxx-xxxxxx,

xxxxxxxxxx ze xxx 9. června 2017 pro xxxxxxxxxxx (XXX); 4-(2,2-xxxxxxx-1,3-xxxxxxxxxxx-4-xx)-1X-xxxxxx-3-xxxxxxxxxxx,

xxxxxxxxxx xx xxx 22. xxxx 2017 xxx xxxxxxxxxxxx-xxxxxx (XXX); xxxxxx-3-xxxxx-5-{[(4,6-xxxxxxxxxxxxxxxxxx-2-xx)xxxxxxxxx]xxxxxxxxx}-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx,

xxxxxxxxxx xx xxx 5. xxxxxxxx 2017 xxx 2-xxxxxxxxxxxxxx,

stanovisko xx dne 15. xxxxxx 2017 xxx (XX)-2-xxxxxxx-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx; xxxxxxxxxxxx,

xxxxxxxxxx ze xxx 5. xxxxxxxx 2017 pro karboxin (XXX); 2-xxxxxx-X-xxxxx-5,6-xxxxxxx-1,4-xxxxxxxx-3-xxxxxxxxxx; 5,6-dihydro-2-methyl-1,4-oxathiin-3-karboxanilid,

xxxxxxxxxx xx dne 5. xxxxxxxx 2017 xxx xxxxxxxxxxxx (ISO); (XX)-2’-[2-(4-xxxxxxxxxx)-1-(α,α,α-xxxxxxxx-x-xxxxx)xxxxxxxxx]-[4-(xxxxxxxxxxxxxxx)xxxxx]xxxxxxxxxxxxxxxxx [X-xxxxxx ≥ 90 %, X-xxxxxx ≤ 10 % relativní xxxxx] [1] (X)-2’-[2-(4-xxxxxxxxxx)-1-(α,α,α-xxxxxxxx-x-xxxxx)xxxxxxxxx]-[4-(xxxxxxxxxxxxxxx)xxxxx]xxxxxxxxxxxxxxxxx [2],

xxxxxxxxxx ze dne 5. prosince 2017 xxx xxxxxxxxxx(xxxxxx-2,4-xxxxxxx-X,X’)xxx

(3)

Odhady akutní xxxxxxxx (XXX) se xxxxxxxxx xxxxxxx xx xxxxxxxxx xxxxxxxxxxx akutní xxxxxxxx x xxxxxxxx xxxxxxxx xxxxxx x xxxxx xxxxxxxxxxxx xxxxx xxxxxxxxxxxxx xxxx látky xxxxxxxxxx xxxxxx xxxxxxxx. Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxx XXX xx xxxxxxx xxxxxxxxx x xxxxxxx XX xxxxxxxx (ES) x. 1272/2008 xxxxxxxxx xxxxxxxxxxx klasifikace xxxxx x xxxxxxxxx xxxxxxx xxxxxxx pověřeným xxxxxxxxxxxx. Xx xxxxxxx dalších xxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxx xxxx xxxxxxxxx xxxxxxx ATE pro xxxxxxx methylrtuti, xxxxxxxxxxx-2,2‘,2“,2“‘,2“"-(xxxxx-1,2-xxxxxxxxxx)xxxxxxxxxxx, {[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxxx xxxxxxxx, pentanatrium-[(karboxylatomethyl)iminobis(ethylennitril)tetraacetát] (XXXX), ethylenoxid, oxiran x metaldehyd (ISO), 2,4,6,8-xxxxxxxxxxx-1,3,5,7-xxxxxxxxxxxxxxxxxx, kromě těch, xxxxx xxxx navrženy xx xxxxxxxxxxxx Xxxxxx xxx posuzování xxxxx. Xxxxxxx hodnoty XXX xx xxxx xxx xxxxxxxx xx xxxxxxxxxxxxxx xxxxxxx xxxxxxx 3 x xxxxx 3 xxxxxxx VI xxxxxxxx (XX) x. 1272/2008.

(4)

Xx xxxx vědeckém xxxxxxxxxx xx dne 22. xxxx 2017 týkajícím xx kobaltu Xxxxx xxx xxxxxxxxxx xxxxx xxxxxx tuto látku xxxxxxxxxxxx jako xxxxxxxxxx xxxxxxxxx 1X xx xxxxxxxxxxx xxxxxxxxxxxxx xxxxxxx ≥ 0,01 %. Xxxxxxxx xxxxxxx xx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxx xxxx xxxxxxxxxx xxxxx xxxxxxxxx, zejména xxxxx xxx x xxxx xxxxxxxxxxxx xx xxxxxxxxxx xxxx. Xxxx xxxxx zatím xxxxxx xxxxxxx xxxxxxxxxx xxxxxxxxxxxx xxxxx xxx xxxxxx x xxxxxxx 3 x části 3 xxxxxxx VI nařízení (XX) č. 1272/2008, xxxxxxx v xxxxxxx xxxxxxx xx x xxxxxxx x xxxxxxxx 3.6.2 přílohy X xxxxxxxxx xxxxxxxx použije xxxxxx xxxxxxxxxxxx limit ≥ 0,1 %.

(5)

Xx xxxx vědeckém stanovisku xx xxx xxxxxxx 14. xxxx 2017 xxxxxxxxx xx xxxxx xxxxxxxxxxxx Výbor pro xxxxxxxxxx rizik navrhl xxxx xxxxx xxxxxxxxxxxx xxxx karcinogen xxxxxxxxx 2 xxx xxxxxxxxxx. Xxxxxxxx x xxxx, xx xxxxxxxxxxxxx pro xxxxx xxxxxxxx oxidem xxxxxxxxxxx xx xxxxxxx x vdechováním xxxxxxxxxxxxxx xxxxxx xxxxx xxxxxxxxxxxx, xxxxxx xxxxxxxxxx x xxxxxxx rozpustností těchto xxxxxx v xxxxxxx, xx xxxxxx definovat xxxxxxxxxxxx částice oxidu xxxxxxxxxxxx x xxxxxxx xxxxx xxxxxxxxxxxx. Xxxxxxxxxxx xx, xx pozorovanou xxxxxxxx x xxxxxxx x xxxxxxxx rozvoj xxxxxx způsobují xxxxxxx xxxxxxx, xxx xxxxxx xxxxxxxxxx xxxx xxxxxxxxxx. Xxx xx xxxxxxxxx xxxxxxxxxxx klasifikaci xxxxx xxxx xxxxx, xxxxx xxxxxx xxxxxxxxxx, xxxx xx být stanoveny xxxxxxxxxx xxxxxxxx xxx xxxxxxxxxxx a xxxxxxxxxx xxxxx a xxxxx xxxx xxxxx xxxxxxxxxxxx. Xxxxxxx xx se xxxxx xxxx xxxx xxxxx xxxxxxxxx směsí xxxxxxxxxxxx oxid titaničitý xxxxxx xxxxxxxxxx xxxxx xxxx xxxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxxx x xxxxxxxxxxxxx xxxxxxxxxx, xxxxx xx třeba xxxxxxxx, xxx se xxxxxxxxxxxxxx xxxxxxxxx xxx xxxxxx zdraví.

(6)

Xxxxx xxx x látky pentakalium-2,2‘,2“,2“‘,2“"-(ethan-1,2-diylnitril)pentaacetát, {[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx kyselina x xxxxxxxxxxxx-[(xxxxxxxxxxxxxxxxx)xxxxxxxx(xxxxxxxxxxxxx)xxxxxxxxxxx] (XXXX), xxxx xx dle xxxxxxxxxx xx xxxxxxxxxxxx Xxxxxx xxx xxxxxxxxxx rizik xx dne 9. xxxxxx 2017 xxx xx přílohy VI xxxxxxxx (ES) č. 1272/2008 xxxxxxxx xxxxxxxxxxx xxxx chemická xxxxx xxxxxxxxxx xxxxxx toxicitu xxxxxxxxx 4 x xxxxxxx chemická xxxxx xxx specifické cílové xxxxxx po xxxxxxxxx xxxxxxxx (kategorie 2), xxxxxxx xxxx x xxxxxxxxx xxxxxxxxxx xxxxxxx xxxxxx xxxxxxxxxxxx xxxx xxxx xxxxxxxxxxx. Xxxxx xxx x látky xxxxxxxxxxx-2,2‘,2“,2“‘,2“"-(xxxxx-1,2-xxxxxxxxxx)xxxxxxxxxxx x {[(karboxymethyl)imino]bis(ethylennitrilo)}tetraoctová xxxxxxxx, xxxx by xxx xxxxxxxxxx xx xxxxxxxxxxxx Xxxxxx xxx xxxxxxxxxx xxxxx xx xxx 9. xxxxxx 2017 být xx xxxxxxx XX xxxxxxxx (XX) č. 1272/2008 xxxxxxxx xxxxxxxxxxx xxxx xxxxxxxx xxxxx způsobující xxxxxxxxxx xxx xxxxxxxxx 2, xxxxxxx xxxx x dispozici xxxxxxxxxx xxxxxxx xxxxxx xxxxxxxxxxxx xxxx nové xxxxxxxxxxx. Xxxxxxxxxxx xxxxx xxxxxxxxxxx-2,2‘,2“,2“‘,2“"-(xxxxx-1,2-xxxxxxxxxx)xxxxxxxxxxx, {[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx xxxxxxxx x xxxxxxxxxxxx-[(xxxxxxxxxxxxxxxxx)xxxxxxxx(xxxxxxxxxxxxx)xxxxxxxxxxx] (XXXX) xxxx xxxxx xxxxxxxxx xxx xxxxxxxxxx kategorie 1X xx xxxx xxxxxx xxx zařazena, xxxxxxx xxxxxxxx xxxxx posouzení Xxxxxxx xxx xxxxxxxxxx xxxxx s ohledem xx nové xxxxxxx xxxxx x xxxxxxxx xxx xxxxxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxx po xxxxxxx stanovisek Xxxxxx xxx xxxxxxxxxx xxxxx Xxxxxx.

(7)

Xxxxxxxx (XX) č. 1272/2008 by proto xxxx xxx xxxxxxxxxxxxx xxxxxxxx změněno.

(8)

Xxxxxxxx (ES) x. 1272/2008 xxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx, xxxxxxxxxx x xxxxxx xxxxx xxxxx, černouhelný xxxxx, xxxxxxxxxxxxxx. Komise xxxxxxxxx xxxxxxxxxxxxxx klasifikaci, xxxxxxxxxx x xxxxxx xxxxxxx xxxxx xxxxxxxxx Komise (XX) x. 944/2013 (3) x xxxxxxx xx 1. dubna 2016. Xxxxxxxx (ES) x. 1272/2008 xxxx xxxx xxxxxxx nařízením Xxxxxx (XX) 2018/669 (4). X xxxxxx xxxxxxxxxxxxxxx xxxxx xxxx xxxxxxx xxxxx – jejichž platnost xxxxxx dotčena rozsudkem Xxxxxxxxx xx xxxx X-689/13 (5), xxxxx xxx xxxxxxxx xxxxxxxxx Xxxxxxxx xxxxx ve věci X-691/15 X (6) – xxxxxxxx xxxxxxxxx (XX) x. 944/2013 xxxxxx x nařízení (XX) 2018/669 zohledněny. Uvedené xxxxxxxx xxxx použitelné xxx xxx 1. xxxxxxxx 2019. Xxxxxxxx (XX) x. 1272/2008 xx proto mělo xxx s xxxxxxx xx téhož dne xxxxxxxx.

(9)

Xxx bylo zajištěno, xx xxxxxxxxxx látek x xxxxx xxxxx xxx dostatek xxxx xxxxxxxxxxx xx xxxxx xxxxxxxxxxx týkajícím xx xxxxxxxxxxx x xxxxxxxxxx, xxxx xx xxx xxxxxxxxxxxx xxxxxx nařízení xxxxxxxx.

(10)

X zajištění xxxxxxx x xxxxxxxxx, xx xxxx je xxxxxxx xx. 61 xxxx. 2 nařízení (ES) x. 1272/2008, xx xxxxxxxxxx xxxx mít xxxxxxx xxxxxxxxxx ustanovení x xxxxxxxxxxx, xxxxxxxxxx x balení zavedená xxxxx xxxxxxxxx xx xxxxxxxxxxx xxxxxxx xxxx xxxxx jeho xxxxxxxxxxxxx,

XXXXXXX XXXX XXXXXXXX:

Xxxxxx 1

Xxxxx nařízení (XX) x. 1272/2008

Xxxxxxxx (XX) x. 1272/2008 xx mění xxxxx:

1)

xxxxxxx XX xx xxxx x souladu x xxxxxxxx X xxxxxx xxxxxxxx;

2)

xxxxxxx III se xxxx x xxxxxxx x přílohou II xxxxxx xxxxxxxx;

3)

příloha XX xx xxxx x xxxxxxx s přílohou XXX xxxxxx xxxxxxxx.

Xxxxxx 2

Xxxxxx nařízení (XX) x. 1272/2008

Příloha XX nařízení (ES) x. 1272/2008 se xxxxxxxx x xxxxxxx x xxxxxxxx XX xxxxxx xxxxxxxx.

Xxxxxx 3

Xxxxx v xxxxxxxx a xxxxxxxxxxxx

Xxxx xxxxxxxx xxxxxxxx v xxxxxxxx xxxxxxxx xxxx xx xxxxxxxxx x Xxxxxxx věstníku Xxxxxxxx xxxx.

Xxxxxxx xx xxx xxx 1. xxxxx 2021.

Xxxxxx 2 xx xxxx xxxxxxx xxx xxx 1. xxxxxxxx 2019.

Xxxxx a xxxxx xxxxx xxx xxx xxxxx dnem 1. xxxxx 2021 klasifikovány, xxxxxxxxxx a xxxxxx x xxxxxxx x xxxxxxxxx (XX) x. 1272/2008 xx xxxxx xxxxxx nařízení.

Xxxx xxxxxxxx xx xxxxxxx v xxxxx xxxxxxx x xxxxx xxxxxxxxxx ve xxxxx členských xxxxxxx.

X Xxxxxxx dne 4. xxxxx 2019.

Xx Xxxxxx

Xxxxxxxx

Xxxx-Xxxxxx XXXXXXX


(1)&xxxx;&xxxx;Xx. xxxx. X 353, 31.12.2008, x. 1.

(2)&xxxx;&xxxx;xxxxx://xxxx.xxxxxx.xx/xxxxxxxx-xx-xxx-xxxxxxxxxx-xxxxx-xxxxxxx/-/xxxxxxx/xxxx/-/xxXxxxxx/-/xxxXxxxxx/-/xxx_xxxxxxxXxxx/-/xxx_xxxxxxxXx/-/xxx_xxxxxx_xxxxxx/Xxxxxxx+Xxxxxxx/xxx_xxxxxxxxxXxxx/-/xxx_xxxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxxxxxxXxxx/-/xxx_xxxxxxxx_xxxxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxxxxXxxx/-/xxx_xxxxxxxx_xxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxx/-/xxx_xxxxxxxxx/-/xxx_xxxxxxxxxxXxxx/-/xxx_xxxxxxxxxxXx/-/xxx_xxxxxxxxxx_xxxxxxxxx/-/

(3)&xxxx;&xxxx;Xxxxxxxx Komise (XX) x. 944/2013 xx xxx 2. xxxxx 2013, kterým se xxx xxxxx xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Xxxxxxxxxx parlamentu x Rady (XX) x. 1272/2008 x xxxxxxxxxxx, xxxxxxxxxx a xxxxxx látek a xxxxx (Xx. věst. X 261, 3.10.2013, x. 5).

(4)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (EU) 2018/669 ze xxx 16. xxxxx 2018, xxxxxx xx xxx xxxxx xxxxxxxxxxxx xxxxxxxxx x technickému xxxxxxx xxxx nařízení Evropského xxxxxxxxxx x Xxxx (XX) x. 1272/2008 x xxxxxxxxxxx, xxxxxxxxxx x xxxxxx xxxxx x směsí (Xx. xxxx. X 115, 4.5.2018, x. 1).

(5)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxx ze xxx 7. xxxxx 2015, Bilbaína xx Xxxxxxxxxxx x další x. Xxxxxx, X-689/13, XX:X:2015:767.

(6)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxx dvora xx dne 22. xxxxxxxxx 2017, Komise x. Xxxxxxxx xx Xxxxxxxxxxx a další, X-691/15 X, XX:X:2017:882.


PŘÍLOHA X

Xxxx 2 xxxxxxx XX xxxxxxxx (XX) x. 1272/2008 xx xxxx xxxxx:

1)

Xxxxxx xxxxxxxx se mění xxxxx:

„Xxxxxxxxxx uvedená x xxxxxxxx 2.1 xx 2.10 x x xxxxxx 2.12 xx xxxxxxxxx xxxxxx xxxxx xx. 25 odst. 6.“

2)

Xxxxxxxx se oddíl 2.12, který xxx:

„2.12.

Xxxxx xxxxxxxxxx oxid xxxxxxxxxx

Xxxxxx na obalu xxxxxxxxx xxxxx obsahujících 1 % xxxx xxxx xxxxxx oxidu xxxxxxxxxxxx x aerodynamickém xxxxxxx nejvýše 10 μx xxxx obsahovat xxxx xxxxxxxxxx:

XXX211: „Pozor! Xxx xxxxxxxx xx xxxxx xxxxxxxx xxxxxxxxxx xxxxxxxxxxxx xxxxxxx. Xxxxxxxxxxx xxxxxxxx xxxx mlhu.“

Štítek xx xxxxx xxxxxxxxx xxxxx obsahujících 1 % xxxx xxxx xxxxxx oxidu xxxxxxxxxxxx xxxx xxxxxxxxx xxxx xxxxxxxxxx:

XXX212: Xxxxx! Při xxxxxxx xx xxxx xxxxxxxx xxxxxxxxxx xxxxxxxxxxxx xxxxx. Nevdechujte prach.“

Kromě xxxx xxxx xxxxxx xx xxxxx tekutých x pevných xxxxx, xxx nejsou xxxxxx xxxxxx veřejnosti a xxxxxx xxxxxxxxxxxxx jako xxxxxxxxxx x xxxx xxxxxxxx xxxx XXX211 xxxx XXX212 xxxxxxxxx xxxxxxxx XXX210.“


XXXXXXX II

V příloze XXX xxxxx 3 xxxxxxxx (ES) x. 1272/2008 xx xxxxxxxx xxxx xxxxx EUH 211 x EUH 212, xxxxx znějí:

„EUH211

Jazyk

BG

Внимание! При пулверизация могат да се образуват опасни респирабилни капки. Не вдишвайте пулверизираната струя или мъгла.

XX

¡Xxxxxxxx! Xx rociar xxxxxx xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxx. Xx xxxxxxxx xx xxxxxxx.

XX

Xxxxx! Xxx xxxxxxxx xx xxxxx xxxxxxxx xxxxxxxxxx respirabilní xxxxxxx. Nevdechujte xxxxxxxx xxxx xxxx.

XX

Xxxxxxxx! Xxx xxx danne xxx xxxxxxx xxxxxxxxxx dråber, xåx xxx xxxxxxx. Xxxxå indånding xx xxxxx eller tåge.

DE

Achtung! Xxxx Xxxüxxx können xxxäxxxxxxx xxxxxxxäxxxxx Xxöxxxxxx xxxxxxxxx. Xxxxxxx xxxx Xxxxx xxxxx xxxxxxxx.

XX

Xxxxxxx! Xxxxxxxxxxxx võivad tekkida xxxxxxxx xxxxxxxxxxxxxxx xxxxxx. Xxxxxxxxxx xxxxx või xxx xxxxx sisse xxxxxxx.

XX

Προσοχή! Κατά τον ψεκασμό μπορούν να σχηματιστούν επικίνδυνα εισπνεύσιμα σταγονίδια. Μην αναπνέετε το εκνέφωμα ή τα σταγονίδια.

EN

Warning! Xxxxxxxxx xxxxxxxxxx xxxxxxxx may xx formed xxxx xxxxxxx. Xx xxx xxxxxxx spray xx xxxx.

XX

Xxxxxxxxx! Des gouttelettes xxxxxxxxxxx xxxxxxxxxxx peuvent xx former lors xx xx xxxxxxxxxxxxx. Xx pas respirer xxx xxxxxxxx xx xxx xxxxxxxxxxx.

XX

Xxxx! X’xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxxxxx x chruthú xxxxx x spraeáiltear xx xxxxxx seo. Xx xxxxxxxxx xxxxx xx xxx.

XX

Xxxxxxxxxx! Xxx xxxxxxxx xxxx nastati xxxxxx xxxxxxxxxxxx xxxxxxxx. Xx xxxxxxx xxxxxxx xx xxxxxxx.

XX

Xxxxxxxxxx! Xx xxxx xx xxxxxxxxxxxxxx xxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxx. Xxx respirare x xxxxxx x xx xxxxxx.

XX

Xxxxxīxx! Izsmidzinot xxx veidoties xīxxxxx xxxxxxxxxx xxxxxxx. Xx xxxxxxxāxxxx, ne xxxxx xxxxxxxxx.

XX

Xxxxxxxxx! Xxxxxxxxx gali xxxxxxxxxx xxxxxxxxų įxxxxxxxų xxxxxxų. Xxįxxėxxx xūxx xx xxxxxxxxx.

XX

Xxxxxxxx! Xxxxxxxxxx xöxxxx veszélyes, xxxxxxxxxxxxő xxxxxxx képződhetnek. X xxxxxxxx vagy x xöxöx nem szabad xxxxxxxxxxx.

XX

Xxxxxxxx! Xxxxx‘ xxxxxxxx xxxx perikoluż li xxxġxxxx man-nifs xxxx xxxxxxxxx xxxx xxx. Xxġxxxx l-isprej xxx x-xxxxxx man-nifs.

NL

Let op! Xxx verneveling kunnen xxxxxxxxxxx inhaleerbare druppels xxxxxx xxxxxxx. Xxxxxxxxxx xxxx inademen.

PL

Uwaga! X xxxxxxxxx xxxxxxxxxx mogą xxę xxxxxxć niebezpieczne xxxxxxxxxxxx kropelki. Xxx xxxxxxć xxxxxxxxxx cieczy xxx xxłx.

XX

Xxxxçãx! Podem xxxxxx-xx gotículas xxxxxxxxx xxxxxxxxx xx xxxxxxxxxx. Xãx respirar x xxxxxxxxxçãx ou xxxxxx.

XX

Xxxxxxxxxx! Xx xxx xxxxx xxxăxxxx xxxxxxxxxxx periculoase xx xxxxxxxxxxx. Nu xxxxxxxțx xxxx pulverizare xxx xxxță.

XX

Xxxxx! Xxx xxxxxxxxxxxx xx môžu xxxxxxxx xxxxxxxxxx respirabilné xxxxôxxx. Xxxxxxxxxxx xxxxxxxx xxx xxxx.

XX

Xxxxx! Pri xxxxxxxxxxxx xxxxx nastanejo xxxxxxx vdihljive kapljice. Xx xxxxxxxxxx xxxxxxxxx xxx meglic.

FI

Varoitus! Xxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxxxx pisaroita xxxxxxx muodostua xxxxxxxxxxxx xxxxxxxxxä. Äxä hengitä xxxxxxxxx tai xxxxx.

XX

Xxxxxxx! Xxxxxxx respirabla xxxxxxx xxx bildas xxx xxxxxxxxx. Xxxxxxx inte xxxxx eller xxxxx.“

„XXX212

Xxxxx

XX

Внимание! При употреба може да се образува опасен респирабилен прах. Не вдишвайте праха.

XX

¡Xxxxxxxx! Xx utilizarse, xxxxx xxxxxxxx xxxxx xxxxxxxxxx xxxxxxxxx. No respirar xx xxxxx.

XX

Xxxxx! Při xxxxxxx se může xxxxxxxx xxxxxxxxxx respirabilní xxxxx. Xxxxxxxxxxx prach.

DA

Advarsel! Xxx xxx xxxxx xxx xxxxxxx xxxxxxxxxxx xxøx xxx xxxxxxxxxxx. Xxxxå xxxåxxxxx xx xxøx.

XX

Xxxxxxx! Xxx xxx Xxxxxxxxxx xxxx gefährlicher xxxxxxxäxxxxxx Staub xxxxxxxxx. Xxxxx nicht xxxxxxxx.

XX

Xxxxxxx! Xxxxxxxxxxx xõxx xxxxxxx xxxxxx xxxxxxxxxxxxx xxxx. Xxxxx xxxxx sisse xxxxxxx.

XX

Προσοχή! Κατά τη χρήση μπορεί να σχηματιστεί επικίνδυνη εισπνεύσιμη σκόνη. Μην αναπνέετε τη σκόνη.

XX

Xxxxxxx! Xxxxxxxxx xxxxxxxxxx xxxx may xx xxxxxx xxxx xxxx. Do not xxxxxxx xxxx.

XX

Xxxxxxxxx! Xxx xxxxxxèxx xxxxxxxxxx xxxxxxxxxx xxxx xx xxxxxx xxxx de l’utilisation. Xx pas xxxxxxxx xxxxx xxxxxxèxx.

XX

Xxxx! D’fhéadfaí xxxxxxxx xxxxxxxxx xxxxxxxxxxx x xxxxxxx xxxxx x xxxxxxxxx xx xxxxxx xxx. Xx xxxxxxxxx xxxxxxxx.

XX

Xxxxxxxxxx! Xxx xxxxxxxx xxxx xxxxxxx xxxxxx xxxxxxxxxxxx xxxxxxx. Xx udisati xxxxxxx.

XX

Xxxxxxxxxx! Xx xxxx xx xxxxxxxx xxxxxxx xxxxxxxx xxxxxxx xxxxxxxxxxx xxxxxxxxxx. Xxx xxxxxxxxx xx xxxxxxx.

XX

Xxxxxīxx! Izmantojot xxx xxxxxxxxx xīxxxxx xxxxxxxxxx xxxxxļx. Putekļus xxxxxxxxx.“

XX

Xxxxxxxxx! Xxxxxxxxx gali xxxxxxxxxx xxxxxxxxų įxxxxxxxų dulkių. Xxįxxėxxx dulkių.

HU

Figyelem! Xxxxxxxxxxxx xxxxxxxxx, xxxxxxxxxxxxő por xxxxőxxxx. A xxxx xxx szabad belélegezni.

MT

Twissija! Xxxx xxxxxżx xxx, xxxxx‘ jifforma xxxx xxxxxxxxż xx xxxġxxxx xxx-xxxx. Xxġxxxx xx-xxxx xxx-xxxx.

XX

Xxx xx! Xxx xxxxxxx xxxxxx gevaarlijke xxxxxxxxxxxx xxxxxxxxxxxx worden xxxxxxx. Xxxx xxxx xxxxxxxx.

XX

Xxxxx! X przypadku xxxxxxxxxx może xxę xxxxxxć niebezpieczny xxł xxxxxxxxxxxx. Nie wdychać xxłx.

XX

Xxxxçãx! Podem xxxxxx-xx xxxxxxx xxxxxxxxx xxxxxxxxx xx pulverizar. Xãx xxxxxxxx xx xxxxxxx.

XX

Xxxxxxxxxx! Xx xxxxx forma xxxxxxx xxxxxxxxxxă periculoasă îx timpul xxxxxxăxxx. Xx inspirați pulberea.

SK

Pozor! Xxx xxxxxxx sa xôxx xxxxxxxx nebezpečný xxxxxxxxxxxx xxxxx. Xxxxxxxxxxx xxxxx.

XX

Xxxxx! Pri uporabi xxxxx xxxxxxx xxxxxxx xxxxxxxx xxxx. Prahu xx xxxxxxxxxx.

XX

Xxxxxxxx! Vaarallista xxxxxxxxxxxxxxxxx xxxxxxxxxxx xöxxä xxxxxxx xxxxxxxxx xäxxöx xxxxxxxxxä. Älä xxxxxxä xöxxä.

XX

Xxxxxxx! Xxxxxxx xxxxxxxxxxx xxxx xxx xxxxxx xxx användning. Inandas xxxx xxxx.“


XXXXXXX XXX

Xxxxxxx XX xxxxxxxx (ES) x. 1272/2008 xx xxxx xxxxx:

1)

xxxx 1 se xxxx xxxxx:

x)

x xxxx 1.1.3.1 se doplňují xxxx xxxxxxxx X x X, xxxxx xxxxx:

„Xxxxxxxx X:

Xxxxxxxx xx xxx xxxxx uvedena xx trh jako xxxxxx (x průměru &xx; 3 μx, xxxxx > 5 μx x x xxxxxxx xxxxx x xxxxxxx ≥ 3:1) xxxx xxxx částice xxxxx xxxxxxxxx xxxxxxxx Xxxxxxx zdravotnické xxxxxxxxxx xxx xxxxxx xxxx xxxx xxxxxxx x xxxxxxxxxxxxx chemickým xxxxxxxx xxxxxxx, xxxxxx xxxxxxxxxx xxxxxxxxxx xxxx být xxxxxxxxxxx x souladu x xxxxxx XX xxxxxx nařízení xxx xxxxxxxxx, xxx xx xx xxxx xxxxxxxx xxxxx kategorie (Xxxx. 1X xxxx 1 X) a/nebo další xxxxx expozice (orální xxxx xxxxxxxx).“

Xxxxxxxx X:

„Xxxx xxxxxxxx, že nebezpečí xxxxxxxxxxxxx xxxx xxxxx xxxxxx, xxxx xx xxxxxxxxx xxxxxxxxxxxx xxxxx x xxxxxxxxxx, jež xxxxx k významnému xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxxx x xxxxxxx.

Xxxxxx xxxx xxxxxxxx xx xxxxxx specifický druh xxxxxxxx dané xxxxx; xxxxxxxxxxxxx kritérium pro xxxxxxxxxxx xxxxx xxxxxx xxxxxxxx.“;

x)

x bodě 1.1.3.2 xx xxxxxxxx xxxx xxxxxxxx 10, xxxxx xxx:

„Xxxxxxxx 10:

Xxxxxxxxxxx xxxx xxxxxxxxxx xxx xxxxxxxxxx xx xxxxxxx pouze xx směsi xx xxxxx xxxxxx xxxxxxxxxxxx 1 % xxxx xxxx xxxxx xxxxxxxxxxxx, xxxxx je xx xxxxx xxxxxx x xxxxxxxxxxxxxx průměru ≤ 10 μm xxxx xx x xxxxxx xxxxxxxxx xxxxxxx.“;

2)

x xxxxx 3 xx tabulka 3 mění xxxxx:

x)

xxxxx x indexovými xxxxx 604-083-00-X x 611-159-00-6 xx xxxxxxx;

x)

xxxxx xxxxxxxxxxxx xxxxxxxxx xxxxxx 015-189-00-5, 027-001-00-9, 028-018-00-4, 603-023-00-X, 605-005-00-7, 606-047-00-9, 607-232-00-7, 607-247-00-9, 608-039-00-0, 613-054-00-0, 616-018-00-2 x 648-055-00-5 xx xxxxxxxxx xxxxxx xxxxxxxxxxxxxx xxxxxxxxx:

Xxxxxxxx xxxxx

Xxxxxxxx xxxxx

Xxxxx XX

Xxxxx CAS

Klasifikace

Označení

Specifické xxxxxxx. limity, xxxxxxxxxxxxx xxxxxxx a ATE

Poznámky

Kódy xxxx a kategorií xxxxxxxxxxxxx

Xxxx xxxxxxxxxxxx xxx x xxxxxxxxxxxxx

Xxxx xxxxxxxxxxx xxxxxxx x xxxxxxxxxx xxxx

Xxxx standardních xxx x xxxxxxxxxxxxx

Xxxx doplň. xxxxxxxxxxxx vět x xxxxxxxxxxxxx

„015-189-00-5

xxxxxxxx(2,4,6-xxxxxxxxxxxxxxxx)xxxxxxxxxx

423-340-5

162881-26-7

Xxxx Xxxx. 1 X

Xxxxxxx Xxxxxxx 4

X317

X413

XXX07

Xxx

X317

X413“

„027-001-00-9

xxxxxx

231-158-0

7440-48-4

Xxxx. 1X

Xxxx. 2

Xxxx. 1X

Xxxx. Xxxx. 1

Xxxx Sens. 1

Xxxxxxx Xxxxxxx 4

X350

X341

X360X

X334

X317

X413

XXX08

Xxx

X350

X341

X360X

X334

X317

X413“

„028-018-00-4

xxxx-xxx(xxxxxxxxxx);

xxxx-xxxxxxxx

237-396-1

13770-89-3

Xxxx. 1 X

Xxxx. 2

Repr. 1X

Xxxxx Xxx. 4

XXXX XX 1

Xxxx. Xxxx. 1

Xxxx Xxxx. 1

Aquatic Xxxxx 1

Aquatic Xxxxxxx 1

X350x

X341

X360X***

X302

X372**

X334

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X350x

X341

X360X***

X302

X372**

X334

X317

X410

xxxxxx: XXX = 853 mg/kg XX (xxxxxxxx)

xxxxxx: ATE = 1&xxxx;098 mg/kg XX (xxxxxxxxxxx)

XXXX XX 1;

X372: X ≥ 1 %

XXXX XX 2;

X373: 0,1 % ≤ X < 1 %

Xxxx Xxxx. 1;

X317: X ≥ 0,01 %

X = 1“

„603-023-00-X

xxxxxxxxxxx;

xxxxxx

200-849-9

75-21-8

Xxxx. Xxx 1

Xxxxx. Xxx

Xxxx. 1X

Xxxx. 1B

Repr. 1B

Acute Xxx. 3

Xxxxx Xxx. 3

XXXX XX 3

XXXX XX 3

XXXX XX 1

Xxxx Xxxx. 1

Eye Xxx. 1

X220

X350

X340

X360Xx

X331

X301

X335

X336

X372 (nervový xxxxxx)

X314

X318

XXX02

XXX08

XXX06

XXX05

Xxx

X220

X350

X340

X360Xx

X331

X301

X335

X336

X372 (nervový systém)

H314

inhalační: XXX = 700ppm (xxxxx)

xxxxxx: XXX = 100 xx/xx XX

X“

„605-005-00-7

xxxxxxxxxx (XXX);

2,4,6,8-xxxxxxxxxxx-1,3,5,7-xxxxxxxxxxxxxxxxxx

203-600-2

108-62-3

Xxxx. Xxx. 2

Xxxx. 2

Xxxxx Tox. 3

Aquatic Xxxxxxx 3

X228

X361x

X301

X412

XXX02

XXX08

XXX06

Xxx

X228

X361x

X301

X412

xxxxxx: ATE = 283 xx/xx XX“

„606-047-00-9

2-xxxxxx-2-xxxxxxxxxxxxx-1-(4-xxxxxxxxxxxxxx)xxxxx-1-xx

404-360-3

119313-12-1

Xxxx. 1B

Aquatic Acute 1

Xxxxxxx Xxxxxxx 1

H360D

H400

H410

GHS08

GHS09

Dgr

H360D

H410“

„607-232-00-7

pyridát (XXX);

X-(6-xxxxx-3-xxxxxxxxxxxxxx-4-xx)-X-xxxxx-xxxxxxxxxxxx

259-686-7

55512-33-9

Xxxxx Xxx. 4

Skin Xxxxx. 2

Skin Xxxx. 1

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

H302

H315

H317

H400

H410

GHS07

GHS09

Wng

H302

H315

H317

H410

orální: XXX = 500 xx/xx XX

X = 1

X = 10“

„607-247-00-9

dodecyl-methakrylát

205-570-6

142-90-5

STOT SE 3

X335

XXX07

Xxx

X335

XXXX XX 3; X335: X ≥ 10 %“

„608-039-00-0

2-xxxxxxxxxxxxxxxx

423-460-8

3508-98-3

Xxxxx Xxx. 4

Xxxxxxx Xxxxxxx 2

H302

H411

GHS07

GHS09

Wng

H302

H411

orální:

ATE = 500 mg/kg XX“

„613-054-00-0

xxxxxxxxxxxx (XXX);

2-(xxxxxxx-4-xx)xxxxxxxxxxxx

205-725-8

148-79-8

Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1

X400

X410

XXX09

Xxx

X410

X = 1

X = 1“

„616-018-00-2

xxxxxxxxxxxxxxx (XXX): X,X-xxxxxxx-x-xxxxxxxx; [DEET]

205-149-7

134-62-3

Acute Tox. 4

Xxxx Xxxxx. 2

Xxx Xxxxx. 2

H302

H315

H319

GHS07

Wng

H302

H315

H319

orální:

ATE = 1&xxxx;892 xx/xx XX“

x)

xxxxxxxx xx xxxx xxxxx:

Xxxxxxxx xxxxx

Xxxxxxxx xxxxx

Xxxxx XX

Xxxxx XXX

Xxxxxxxxxxx

Xxxxxxxx

Xxxxxxxxxx koncent. limity, xxxxxxxxxxxxx faktory x XXX

Xxxxxxxx

Xxxx xxxx x xxxxxxxxx nebezpečnosti

Kódy standardních xxx x nebezpečnosti

Kódy xxxxxxxxxxx symbolů a xxxxxxxxxx xxxx

Xxxx xxxxxxxxxxxx xxx x xxxxxxxxxxxxx

Xxxx xxxxx. xxxxxxxxxxxx vět x xxxxxxxxxxxxx

„022-006-002

xxxx xxxxxxxxxx;

[xx xxxxx xxxxxx obsahujícího 1 % nebo xxxx částic o xxxxxxxxxxxxxx xxxxxxx ≤ 10 μm]

236-675-5

13463-67-7

Carc. 2

H351 (xxxxxxxxxx)

XXX08

Xxx

X351 (xxxxxxxxxx)

X, X, 10

080-012-00-0

xxxxxxx xxxxxxxxxxx

204-064-2

115-09-3

Xxxx. 2

Xxxx. 1 X

Xxxx.

Xxxxx Xxx. 2

Xxxxx Tox. 2

Acute Xxx. 2

XXXX XX 1

Xxxxxxx Acute 1

Xxxxxxx Xxxxxxx 1

H351

H360Df

H362

H330

H310

H300

H372 (nervový xxxxxx, xxxxxxx)

X400

X410

XXX08

XXX06

XXX09

Xxx

X351

X360Xx

X362

X330

X310

X300

X372 (xxxxxxx xxxxxx, xxxxxxx)

X410

xxxxxxxxx: XXX = 0,05 xx/x (xxxxx xxxx mlha)

dermální: XXX = 50 xx/xx TH

orální: ATE = 5 xx/xx XX

1

601-090-00-X

xxxxx[xxx]xxxxxxxx

205-877-5

189-55-9

Xxxx. 1B

Muta. 2

X350

X341

XXX08

Xxx

X350

X341

601-091-00-5

xxxxxxx[x,xxx]xxxxxxx;

xxxxxxx[x,x]xxxxx

205-878-0

189-64-0

Xxxx. 1X

Xxxx. 2

H350

H341

GHS08

Dgr

H350

H341

603-236-00-8

ethanol, 2,2’-xxxxxxxx-, X-(X13-15-xxxxxxxxxx a xxxxxxxx xxxxx) xxxxxxxx

308-208-6

97925-95-6

Xxxx. 1X

X360X

XXX08

Xxx

X360X

607-733-00-0

xxxxxxxxxxxx (XXX);

2-xxxxxxxxxxxx-(XX)-2-(4-xxxx-xxxxxxxxxx)-2-xxxxx-3-xxx-3-(α,α,α-xxxxxxxx-x-xxxxx)xxxxxxxxx

-

400882-07-7

Xxxx. 2

Skin Xxxx. 1 X

X351

X317

XXX08

XXX07

Xxx

X351

X317

607-734-00-6

xxxxxxxxxxx-2,2‘,2“,2“‘,2“"-(xxxxx-1,2-xxxxxxxxxx)xxxxxxxxxxx

404-290-3

7216-95-7

Xxxxx Xxx. 4 XXXX XX 2

Xxx Xxxxx. 2

H332

H373 (xxxxxxxxxx)

X319

XXX08

XXX07

Xxx

X332

X373 (xxxxxxxxxx)

X319

xxxxxxxxx:

XXX = 1,5 mg/l (xxxxx xxxx mlha)

607-735-00-1

{[(karboxymethyl)imino]bis(ethylennitrilo)}tetraoctová xxxxxxxx

200-652-8

67-43-6

Xxxxx Xxx. 4 XXXX XX 2

Eye Xxxxx. 2

X332

X373 (xxxxxxxxxx)

X319

XXX08

XXX07

Xxx

X332

X373 (xxxxxxxxxx)

X319

xxxxxxxxx:

XXX = 1,5 xx/x (xxxxx xxxx mlha)

607-736-00-7

pentanatrium-[(karboxylatomethyl)iminobis(ethylennitril)tetraacetát]

205-391-3

140-01-2

Acute Xxx. 4

XXXX XX 2

X332

X373 (vdechování)

GHS08

GHS07

Dgr

H332

H373 (xxxxxxxxxx)

xxxxxxxxx:

XXX = 1,5 mg/l (xxxxx xxxx xxxx)

607-737-00-2

xxxxxxxxxx-xxxxxx

276-090-2

71850-09-4

Xxxx. 1X

X360XX

XXX08

Xxx

X360XX

608-069-00-4

xxxxxxxxxxx (ISO); 4-(2,2-xxxxxxx-1,3-xxxxxxxxxxx-4-xx)-1X-xxxxxx-3-xxxxxxxxxxx

-

131341-86-1

Xxxxxxx Xxxxx 1

Aquatic Chronic 1

X400

X410

XXX09

Xxx

X410

X = 1

X = 10

613-329-00-5

halosulfuron-methyl (ISO);

methyl-3-chlor-5-{[(4,6-dimethoxypyrimidin-2-yl)karbamoyl]sulfamoyl}-1-methyl-1H-pyrazol-4-karboxylát

-

100784-20-1

Repr. 1X

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

H360D

H400

H410

GHS08

GHS09

Dgr

H360D

H410

M = 1&xxxx;892

X = 1 000

613-330-00-0

2-methylimidazol

211-765-7

693-98-1

Repr. 1X

X360Xx

XXX08

Xxx

X360Xx

616-225-00-8

(XX)-2-xxxxxxx-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx; xxxxxxxxxxxx

-

173662-97-0

Xxxxxxx Xxxxx 1 Aquatic Chronic 1

X400

X410

XXX09

Xxx

X410

X = 1

X = 10

616-226-00-3

xxxxxxxx (XXX);

2-xxxxxx-X-xxxxx-5,6-xxxxxxx-1,4-xxxxxxxx-3-xxxxxxxxxx; 5,6-xxxxxxx-2-xxxxxx-1,4-xxxxxxxx-3-xxxxxxxxxxxx

226-031-1

5234-68-4

XXXX XX 2

Skin Xxxx. 1

Aquatic Acute 1

Xxxxxxx Xxxxxxx 1

H373 (xxxxxxx)

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X373 (xxxxxxx)

X317

X410

X = 1

X = 1

616-227-00-9

xxxxxxxxxxxx (XXX); (XX)-2’-[2-(4-xxxxxxxxxx)-1-(α,α,α-xxxxxxxx-x-xxxxx)xxxxxxxxx]-[4-(xxxxxxxxxxxxxxx)xxxxx]xxxxxxxxxxxxxxxxx [X-xxxxxx ≥ 90 %, X-xxxxxx ≤ 10 % xxxxxxxxx obsah]; [1]

(X)-2’-[2-(4-xxxxxxxxxx)-1-(α,α,α-xxxxxxxx-x-xxxxx)xxxxxxxxx]-[4-(xxxxxxxxxxxxxxx)xxxxx]xxxxxxxxxxxxxxxxx [2]

-

139968-49-3 [1]

852403-68-0 [2]

Xxxx. 2

Xxxx.

XXXX XX 2

X361xx

X362

X373

XXX08

Xxx

X361xx

X362

X373

650-056-00-0

xxxxxxxxxx(xxxxxx-2,4-xxxxxxx-X,X’)xxx

245-152-0

22673-19-4

Xxxx. 1X

XXXX XX 1

X360XX

X372 (xxxxxxxx systém)

GHS08

Dgr

H360FD

H372 (xxxxxxxx xxxxxx)“.


XXXXXXX IV

V příloze XX xxxxxxxx (XX) x. 1272/2008 xx x xxxxxxx 3 xxxxx x xxxxxxxxx xxxxxx „648-055-00-5“ nahrazuje xxxxx:

Xxxxxxxx xxxxx

Xxxxxxxx xxxxx

Xxxxx XX

Xxxxx XXX

Xxxxxxxxxxx

Xxxxxxxx

Xxxxxxxxxx xxxxxxx. xxxxxx, xxxxxxxxxxxxx xxxxxxx x XXX

Xxxxxxxx

Xxxx xxxx x xxxxxxxxx xxxxxxxxxxxxx

Xxxx xxxxxxxxxxxx vět x xxxxxxxxxxxxx

Xxxx výstražných xxxxxxx x xxxxxxxxxx xxxx

Xxxx xxxxxxxxxxxx xxx o xxxxxxxxxxxxx

Xxxx xxxxx. xxxxxxxxxxxx xxx x xxxxxxxxxxxxx

„648-055-00-5

xxxxx, xxxxxxxxxxx dehet, xxxxxxxxxxxxxx; [Xxxxxxxxxx xxxxxx z xxxxxxxxx xxxxxxxxxxxxxxxx černouhelného xxxxx. Xxxxx xxxx xxxxx x xxxxxxxxxx xxxxxxxx xxxxxxx od 30 °C xx 180 °X. Xx xxxxxxx převážně xx xxxxxxx xxxxx xxxxxxxxxxxx xxxxxxxxxx xx xxxxx x xxxx xxxxxxxxxxxxxx xxxxx.]

266-028-2

65996-93-2

Xxxx. 1 X

Xxxx. 1X

Xxxx. 1X

X350

X340

X360XX

XXX08

Xxx

X350

X340

X360XX“.